Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.
ServicesFrederick Locke, MD provides internal medicine in Tampa, FL. Frederick Locke, MD is listed as an internist, which is a physician who studies Internal Medicine for adults.
To learn more, or to make an appointment with Moffitt Magnolia Campus in Tampa, FL, please call (888) 663-3488.